摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-dimethylamino-4-phenyl-4-[4]pyridyl-hexan-3-one | 109865-60-3

中文名称
——
中文别名
——
英文名称
6-dimethylamino-4-phenyl-4-[4]pyridyl-hexan-3-one
英文别名
6-Dimethylamino-4-phenyl-4-[4]pyridyl-hexan-3-on
6-dimethylamino-4-phenyl-4-[4]pyridyl-hexan-3-one化学式
CAS
109865-60-3
化学式
C19H24N2O
mdl
——
分子量
296.412
InChiKey
YAKNXMUQOXOZIE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    22.0
  • 可旋转键数:
    7.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.37
  • 拓扑面积:
    33.2
  • 氢给体数:
    0.0
  • 氢受体数:
    3.0

反应信息

点击查看最新优质反应信息

文献信息

  • Basic ketones and a process of preparing them
    申请人:HOECHST AG
    公开号:US02731462A1
    公开(公告)日:1956-01-17

    The invention comprises basic ketones of the formula <;FORM:0719237/IV (b)/1>; p in which R1 and R2 each represent an alkyl radical having up to 6 carbon atoms or together represent a four- or five-membered divalent residue, R3 represents a methylene group or a methylene group containing as a substituent an alkyl radical having up to 6 carbon atoms, R4 represents the residue of pyridine, thiazole or pyrimidine a ring carbon atom of which is directly bound to the central C-atom, R5 represents a phenyl, hydroxy-phenyl or alkoxy-phenyl radical and R7 represents an alkyl radical containing up to 6 carbon atoms, and salts of such basic ketones. Such compounds are obtained by reacting a carboxylic acid ester of the formula <;FORM:0719237/IV (b)/2>; with an alkyl magnesium halide, and, if desired, converting the free base so obtained into a salt. The carboxylic acid esters are produced by reacting an ester of the formula R4R5CH.COO.Alkyl with a basically substituted alkyl halide. Better yields are generally obtained when "Alkyl" in the ester is a branched alkyl radical. Salts of the above compounds mentioned are those with sulphuric, hydrochloric, phosphoric, acetic, propionic, benzoic and ethane sulphonic acids, and (for identification purposes) the succinic and maleic acid salts. In an example: (1) a - phenyl - a - pyridyl - (2) - g - N - pyrrolidino-butyric acid ethyl ester (prepared by reacting phenyl-pyridyl-(2)-acetic acid ethyl ester and N-b -chlorethyl-pyrrolidine in the presence of sodamide) is reacted with ethyl magnesium bromide to give 1-N-pyrrolidino-3-phenyl-3-pyridyl-(2)-hexanone, which is converted to its succinate. Similarly prepared are (2) 1 - dimethylamino - 3 - phenyl - 3 - pyridyl - (21) - hexanone - (4) from a - phenyl - a - pyridyl - (2) - g - dimethylamino - butyric acid ethyl ester; (3) 1-N-morpholino-3-phenyl-3-pyridyl-(21)-hexanone-(4) from a -phenyl-a -pyridyl-(2)-g -N-morpholino-butyric acid ethyl or isopropyl ester; (4) an isomeric mixture of 2-dimethylamino-4-phenyl-4-pyridyl-(21)-heptanone-(5) and 1 - dimethylamino - 2 - methyl - 3 - phenyl - 3-pyridyl-(21)-hexanone-(4) from an isomeric mixture of a -phenyl-a -pyridyl-(2)-g -dimethylamino-valeric acid and a -phenyl-a -pyridyl-(2)-b - methyl - g - dimethylamino - butyric acid ethyl ester; (5) 1-dimethylamino-3-phenyl-3-pyridyl - (41) - hexanone - (4) from phenyl - pyridyl-(4)-acetic acid ethyl ester; (6) 1-dimethylamino - 3 - phenyl - 3 - thiazolyl - (21) - hexanone-(4) from a -phenyl-a -thiazolyl-(2)-g -dimethylamino-butyric acid ethyl ester; (7) 1-N - pyrrolidino - 3 - phenyl - 3 - thiazolyl - (21) - hexanone-(4) from a -phenyl-a -thiazolyl-(2)-g -N-pyrrolidino-butyric acid methyl ester; (8) 1 - N - piperidino - 3 - phenyl - 3 - thiazolyl - (21) - hexanone - (4) from a - phenyl - a - thiazolyl - (2) - g - N - piperidino - butyric acid methyl ester; (9) 1-N-morpholino-3-phenyl-3-thiazolyl-(21)-hexanone-(4) from a -phenyl-a -thiazolyl-(2)-g -N-morpholino-butyric acid methyl ester; (10) 1 - diethylamino - 3 - phenyl - 3 - thiazolyl-(21) - hexanone - (4) from a - phenyl - a - thiazolyl - (2) - g - diethylamino - butyric acid ethyl ester; (11) 1-dimethylamino-3-(31-methoxy - phenyl) - 3 - thiazolyl - (21) - hexanone - (4) from a - (31 - methoxy - phenyl) - a - thiazolyl - (21) - g - dimethylamino - butyric acid methyl ester. The product is converted to the corresponding 31-hydroxy-phenyl derivative by boiling with hydrobromic acid; (12) 1-dimethylamino - 3 - phenyl - 3 - pyrimidyl - (21) - hexanone - (4) from a - phenyl - a - pyrimidyl - (2) - butyric acid ethyl ester. Most of the products are converted to their succinate or maleate. In example (4) the product is separated into its isomers by fractional crystallization of the maleates. In each example the preparation of the specified starting material by a method analogous to that employed in the corresponding stage in example (1) is described.

    该发明包括公式<;FORM:0719237/IV(b)/1>;p中的基本酮,其中R1和R2分别代表具有高达6个碳原子的烷基基团或共同代表四元或五元二价残基,R3代表甲基基团或含有高达6个碳原子的烷基基团的亚甲基基团取代物,R4代表吡啶噻唑嘧啶的残基,其环碳原子直接与中央C原子相连,R5代表苯基,羟基苯基或烷氧基苯基基团,R7代表含有高达6个碳原子的烷基基团,以及这些基本酮的盐。通过将公式<;FORM:0719237/IV(b)/2>;的羧酸酯与烷基卤化物反应,如果需要,将所得的自由碱转化为盐,可以获得这样的化合物。当酯中的“烷基”是支链烷基时,通常可以获得更好的产率。上述化合物的盐是硫酸盐酸磷酸乙酸丙酸苯甲酸乙烯磺酸盐以及(用于鉴定目的)琥珀酸马来酸盐。例如:(1)-苯基-α-吡啶基-(2)-γ-N-吡咯烷基-丁酸乙酯(通过在苏打胺存在下反应苯基-吡啶基-(2)-乙酸乙酯和N-b-乙基-吡咯烷基)与乙基反应,得到1-N-吡咯烷基-3-苯基-3-吡啶基-(2)-己酮,转化为其琥珀酸盐。类似地制备了(2)1-二甲基基-3-苯基-3-吡啶基-(21)-己酮-(4)来自-苯基-α-吡啶基-(2)-γ-二甲基基-丁酸乙酯;(3)1-N-吗啡基-3-苯基-3-吡啶基-(21)-己酮-(4)来自-苯基-α-吡啶基-(2)-γ-N-吗啡基-丁酸乙酯或异丙酯;(4)2-二甲基基-4-苯基-4-吡啶基-(21)-庚酮-(5)和1-二甲基基-2-甲基-3-苯基-3-吡啶基-(21)-己酮-(4)的异构混合物来自-苯基-α-吡啶基-(2)-γ-二甲基基-戊酸和-苯基-α-吡啶基-(2)-β-甲基-γ-二甲基基-丁酸乙酯的异构混合物;(5)1-二甲基基-3-苯基-3-吡啶基-(41)-己酮-(4)来自苯基-吡啶基-(4)-乙酸乙酯;(6)1-二甲基基-3-苯基-3-噻唑基-(21)-己酮-(4)来自-苯基-α-噻唑基-(2)-γ-二甲基基-丁酸乙酯;(7)1-N-吡咯烷基-3-苯基-3-噻唑基-(21)-己酮-(4)来自-苯基-α-噻唑基-(2)-γ-N-吡咯烷基-丁酸甲酯;(8)1-N-哌啶基-3-苯基-3-噻唑基-(21)-己酮-(4)来自-苯基-α-噻唑基-(2)-γ-N-哌啶基-丁酸甲酯;(9)1-N-吗啡基-3-苯基-3-噻唑基-(21)-己酮-(4)来自-苯基-α-噻唑基-(2)-γ-N-吗啡基-丁酸甲酯;(10)1-二乙基基-3-苯基-3-噻唑基-(21)-己酮-(4)来自-苯基-α-噻唑基-(2)-γ-二乙基基-丁酸乙酯;(11)1-二甲基基-3-(31-甲氧基-苯基)-3-噻唑基-(21)-己酮-(4)来自-(31-甲氧基-苯基)-α-噻唑基-(21)-γ-二甲基基-丁酸甲酯。通过与氢溴酸沸腾,将产物转化为相应的31-羟基苯基衍生物;(12)1-二甲基基-3-苯基-3-嘧啶基-(21)-己酮-(4)来自-苯基-α-嘧啶基-(2)-丁酸乙酯。大多数产品都转化为其琥珀酸盐或马来酸盐。在例(4)中,通过马来酸盐的分级结晶将产物分离成其异构体。在每个例子中,描述了通过类似于在例(1)中使用的方法制备指定起始材料的方法。

查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)